Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions Journal Article


Authors: Mata, D. A.; Benhamida, J. K.; Lin, A. L.; Vanderbilt, C. M.; Yang, S. R.; Villafania, L. B.; Ferguson, D. C.; Jonsson, P.; Miller, A. M.; Tabar, V.; Brennan, C. W.; Moss, N. S.; Sill, M.; Benayed, R.; Mellinghoff, I. K.; Rosenblum, M. K.; Arcila, M. E.; Ladanyi, M.; Bale, T. A.
Article Title: Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
Abstract: A subset of glioblastomas (GBMs) harbors potentially druggable oncogenic FGFR3-TACC3 (F3T3) fusions. However, their associated molecular and clinical features are poorly understood. Here we analyze the frequency of F3T3-fusion positivity, its associated genetic and methylation profiles, and its impact on survival in 906 IDH-wildtype GBM patients. We establish an F3T3 prevalence of 4.1% and delineate its associations with cancer signaling pathway alterations. F3T3-positive GBMs had lower tumor mutational and copy-number alteration burdens than F3T3-wildtype GBMs. Although F3T3 fusions were predominantly mutually exclusive with other oncogenic RTK pathway alterations, they did rarely co-occur with EGFR amplification. They were less likely to harbor TP53 alterations. By methylation profiling, they were more likely to be assigned the mesenchymal or RTK II subclass. Despite being older at diagnosis and having similar frequencies of MGMT promoter hypermethylation, patients with F3T3-positive GBMs lived about 8 months longer than those with F3T3-wildtype tumors. While consistent with IDH-wildtype GBM, F3T3-positive GBMs exhibit distinct biological features, underscoring the importance of pursuing molecular studies prior to clinical trial enrollment and targeted treatment.
Keywords: f3t3; fgfr3-tacc3 fusion; idh-wildtype glioblastoma
Journal Title: Acta Neuropathologica Communications
Volume: 8
ISSN: 2051-5960
Publisher: BioMed Central Ltd.  
Date Published: 2020-11-09
Start Page: 186
Language: English
DOI: 10.1186/s40478-020-01058-6
PUBMED: 33168106
PROVIDER: scopus
PMCID: PMC7653727
DOI/URL:
Notes: Article -- Export Date: 1 December 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Viviane S Tabar
    220 Tabar
  2. Cameron Brennan
    222 Brennan
  3. Marc Rosenblum
    423 Rosenblum
  4. Marc Ladanyi
    1318 Ladanyi
  5. Maria Eugenia Arcila
    653 Arcila
  6. Alexandra Miller
    74 Miller
  7. Rym Benayed
    187 Benayed
  8. Karl Philip Jonsson
    50 Jonsson
  9. Nelson Moss
    85 Moss
  10. Andrew Lee Lin
    60 Lin
  11. Tejus Bale
    117 Bale
  12. Douglas Alexander Mata
    27 Mata
  13. Soo Ryum Yang
    72 Yang